{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T03:22:09Z","timestamp":1791602529405,"version":"4.3.4"},"reference-count":99,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001412","name":"Council of Scientific & Industrial Research","doi-asserted-by":"publisher","award":["MLP 0138"],"award-info":[{"award-number":["MLP 0138"]}],"id":[{"id":"10.13039\/501100001412","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001407","name":"Department of Biotechnology, Ministry of Science and Technology, India","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001407","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.bbadis.2025.167886","type":"journal-article","created":{"date-parts":[[2025,5,3]],"date-time":"2025-05-03T02:31:57Z","timestamp":1746239517000},"page":"167886","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Generation and characterization of a chronic in vitro model to study the early stage of metabolic dysfunction-associated steatotic liver disease (MASLD)"],"prefix":"10.1016","volume":"1871","author":[{"given":"Vandana","family":"Singh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Partha","family":"Chattopadhyay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabeha","family":"Fatima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Praveen","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajesh","family":"Pandey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anurag","family":"Agrawal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soumya Sinha","family":"Roy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.bbadis.2025.167886_bb0005","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1097\/HEP.0000000000000004","article-title":"The global epidemiology of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH): a systematic review","volume":"77","author":"Younossi","year":"2023","journal-title":"Hepatology"},{"key":"10.1016\/j.bbadis.2025.167886_bb0010","doi-asserted-by":"crossref","unstructured":"Henry L, Younossi ZM. Epidemiology and natural history of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis. InNeed-to-know NAFLD 2024 (pp. 10-22). CRC Press.","DOI":"10.1201\/9781003386698-3"},{"key":"10.1016\/j.bbadis.2025.167886_bb0015","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/hep.28431","article-title":"Global epidemiology of nonalcoholic fatty liver disease\u2014meta-analytic assessment of prevalence, incidence, and outcomes","volume":"64","author":"Younossi","year":"2016","journal-title":"Hepatology"},{"issue":"6","key":"10.1016\/j.bbadis.2025.167886_bb0020","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1016\/S0016-5085(99)70506-8","article-title":"Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity","volume":"116","author":"Matteoni","year":"1999","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bbadis.2025.167886_bb0025","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1126\/science.1204265","article-title":"Human fatty liver disease: old questions and new insights","volume":"332","author":"Cohen","year":"2011","journal-title":"Science"},{"issue":"3","key":"10.1016\/j.bbadis.2025.167886_bb0030","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1016\/j.jhep.2010.11.021","article-title":"Presence and significance of microvesicular steatosis in nonalcoholic fatty liver disease","volume":"55","author":"Tandra","year":"2011","journal-title":"J. Hepatol."},{"key":"10.1016\/j.bbadis.2025.167886_bb0035","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/s12916-017-0806-8","article-title":"Non-alcoholic fatty liver disease","volume":"15","author":"Neuschwander-Tetri","year":"2017","journal-title":"BMC Med."},{"key":"10.1016\/j.bbadis.2025.167886_bb0040","doi-asserted-by":"crossref","first-page":"3313","DOI":"10.1007\/s00018-018-2860-6","article-title":"Molecular mechanisms of hepatic lipid accumulation in non-alcoholic fatty liver disease","volume":"75","author":"Ipsen","year":"2018","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.bbadis.2025.167886_bb0045","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000010214","article-title":"Components of metabolic syndrome increase the risk of mortality in nonalcoholic fatty liver disease (NAFLD)","volume":"97","author":"Golabi","year":"2018","journal-title":"Medicine"},{"issue":"10290","key":"10.1016\/j.bbadis.2025.167886_bb0050","doi-asserted-by":"crossref","first-page":"2212","DOI":"10.1016\/S0140-6736(20)32511-3","article-title":"Non-alcoholic fatty liver disease","volume":"397","author":"Powell","year":"2021","journal-title":"Lancet"},{"issue":"48","key":"10.1016\/j.bbadis.2025.167886_bb0055","doi-asserted-by":"crossref","first-page":"S104","DOI":"10.1016\/j.jhep.2008.01.009","article-title":"Non-alcoholic fatty liver disease: the mist gradually clears","volume":"1","author":"de Alwis","year":"2008","journal-title":"J. Hepatol."},{"key":"10.1016\/j.bbadis.2025.167886_bb0060","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1007\/s00392-020-01709-7","article-title":"NAFLD and cardiovascular diseases: a clinical review","volume":"110","author":"Kasper","year":"2021","journal-title":"Clin. Res. Cardiol."},{"issue":"6","key":"10.1016\/j.bbadis.2025.167886_bb0065","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1111\/dom.15016","article-title":"Nonalcoholic fatty liver disease from a primary care perspective","volume":"25","author":"Clark","year":"2023","journal-title":"Diabetes Obes. Metab."},{"key":"10.1016\/j.bbadis.2025.167886_bb0070","doi-asserted-by":"crossref","unstructured":"Allen AM, Lazarus JV, Younossi ZM. Healthcare and socioeconomic costs of NAFLD: a global framework to navigate the uncertainties. J. Hepatol. 2023 Jul 1;79(1):209\u201317.","DOI":"10.1016\/j.jhep.2023.01.026"},{"issue":"16","key":"10.1016\/j.bbadis.2025.167886_bb0075","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.cotox.2019.03.001","article-title":"Human in vitro models of nonalcoholic fatty liver disease","volume":"1","author":"M\u00fcller","year":"2019","journal-title":"Curr. Opin. Toxicol."},{"issue":"15","key":"10.1016\/j.bbadis.2025.167886_bb0080","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1177\/1535370216657448","article-title":"Cell sources for in vitro human liver cell culture models","volume":"241","author":"Zeilinger","year":"2016","journal-title":"Exp. Biol. Med."},{"key":"10.1016\/j.bbadis.2025.167886_bb0085","doi-asserted-by":"crossref","unstructured":"G\u00f3mez-Lech\u00f3n MJ, Donato MT, Mart\u00ednez-Romero A, Jim\u00e9nez N, Castell JV, O'Connor JE. A human hepatocellular in vitro model to investigate steatosis. Chem. Biol. Interact. 2007 Jan 30;165(2):106\u201316.","DOI":"10.1016\/j.cbi.2006.11.004"},{"key":"10.1016\/j.bbadis.2025.167886_bb0090","doi-asserted-by":"crossref","unstructured":"Soret PA, Magusto J, Housset C, Gautheron J. In vitro and in vivo models of non-alcoholic fatty liver disease: a critical appraisal. J. Clin. Med. 2020 Dec 24;10(1):36.","DOI":"10.3390\/jcm10010036"},{"key":"10.1016\/j.bbadis.2025.167886_bb0095","doi-asserted-by":"crossref","unstructured":"Rai P, Kumar M, Sharma G, Barak P, Das S, Kamat SS, Mallik R. Kinesin-dependent mechanism for controlling triglyceride secretion from the liver. Proc. Natl. Acad. Sci. 2017 Dec 5;114(49):12958\u201363.","DOI":"10.1073\/pnas.1713292114"},{"issue":"2","key":"10.1016\/j.bbadis.2025.167886_bb0100","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1111\/j.1478-3231.2005.01017.x","article-title":"Liver cell lines for the study of hepatocyte functions and immunological response","volume":"25","author":"Clayton","year":"2005","journal-title":"Liver Int."},{"key":"10.1016\/j.bbadis.2025.167886_bb0105","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12944-017-0551-1","article-title":"Free fatty acids profile among lean, overweight and obese non-alcoholic fatty liver disease patients: a case\u2013control study","volume":"16","author":"Feng","year":"2017","journal-title":"Lipids Health Dis."},{"key":"10.1016\/j.bbadis.2025.167886_bb0110","doi-asserted-by":"crossref","unstructured":"Kwon Y, Gottmann P, Wang S, Tissink J, Motzler K, Sekar R, Albrecht W, Cadenas C, Hengstler JG, Sch\u00fcrmann A, Zeigerer A. Induction of steatosis in primary human hepatocytes recapitulates key pathophysiological aspects of metabolic dysfunction-associated steatotic liver disease. J. Hepatol. 2025 Jan 1;82(1):18\u201327.","DOI":"10.1016\/j.jhep.2024.06.040"},{"key":"10.1016\/j.bbadis.2025.167886_bb0115","doi-asserted-by":"crossref","unstructured":"Shao Y, Chen S, Han L, Liu J. Pharmacotherapies of NAFLD: updated opportunities based on metabolic intervention. Nutrition & Metabolism. 2023 Jul 6;20(1):30.","DOI":"10.1186\/s12986-023-00748-x"},{"issue":"3","key":"10.1016\/j.bbadis.2025.167886_bb0120","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.cmet.2010.06.009","article-title":"Hepatic-specific disruption of SIRT6 in mice results in fatty liver formation due to enhanced glycolysis and triglyceride synthesis","volume":"12","author":"Kim","year":"2010","journal-title":"Cell Metab."},{"issue":"1","key":"10.1016\/j.bbadis.2025.167886_bb0125","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.biocel.2006.07.001","article-title":"Free radicals and antioxidants in normal physiological functions and human disease","volume":"39","author":"Valko","year":"2007","journal-title":"Int. J. Biochem. Cell Biol."},{"issue":"10","key":"10.1016\/j.bbadis.2025.167886_bb0130","doi-asserted-by":"crossref","first-page":"R453","DOI":"10.1016\/j.cub.2014.03.034","article-title":"ROS function in redox signaling and oxidative stress","volume":"24","author":"Schieber","year":"2014","journal-title":"Curr. Biol."},{"key":"10.1016\/j.bbadis.2025.167886_bb0135","series-title":"Cheng KK","first-page":"e13856","author":"Mansoori","year":"2024"},{"issue":"2","key":"10.1016\/j.bbadis.2025.167886_bb0140","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1080\/15548627.2023.2254191","article-title":"Dysfunction of autophagy in high-fat diet-induced non-alcoholic fatty liver disease","volume":"20","author":"Ren","year":"2024","journal-title":"Autophagy"},{"issue":"3","key":"10.1016\/j.bbadis.2025.167886_bb0145","doi-asserted-by":"crossref","first-page":"210","DOI":"10.3350\/cmh.2013.19.3.210","article-title":"Nonalcoholic fatty liver disease: molecular mechanisms for the hepatic steatosis","volume":"19","author":"Koo","year":"2013","journal-title":"Clin. Mol. Hepatol."},{"issue":"1","key":"10.1016\/j.bbadis.2025.167886_bb0150","first-page":"6675762","article-title":"Emerging roles of impaired autophagy in fatty liver disease and hepatocellular carcinoma","volume":"2021","author":"Niture","year":"2021","journal-title":"Int. J. Hepatol."},{"issue":"6","key":"10.1016\/j.bbadis.2025.167886_bb0155","doi-asserted-by":"crossref","first-page":"1994","DOI":"10.1002\/hep.28820","article-title":"Rubicon inhibits autophagy and accelerates hepatocyte apoptosis and lipid accumulation in nonalcoholic fatty liver disease in mice","volume":"64","author":"Tanaka","year":"2016","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.bbadis.2025.167886_bb0160","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.livres.2018.09.004","article-title":"Autophagy in non-alcoholic fatty liver disease and alcoholic liver disease","volume":"2","author":"Khambu","year":"2018","journal-title":"Liver res."},{"issue":"8","key":"10.1016\/j.bbadis.2025.167886_bb0165","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.4161\/auto.6826","article-title":"Selective turnover of p62\/A170\/SQSTM1 by autophagy","volume":"4","author":"Ichimura","year":"2008","journal-title":"Autophagy"},{"issue":"3","key":"10.1016\/j.bbadis.2025.167886_bb0170","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1053\/j.gastro.2014.11.039","article-title":"Nonalcoholic steatohepatitis is the second leading etiology of liver disease among adults awaiting liver transplantation in the United States","volume":"148","author":"Wong","year":"2015","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bbadis.2025.167886_bb0175","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1007\/s00535-013-0758-5","article-title":"Mechanisms of hepatic triglyceride accumulation in non-alcoholic fatty liver disease","volume":"48","author":"Kawano","year":"2013","journal-title":"J. Gastroenterol."},{"issue":"6","key":"10.1016\/j.bbadis.2025.167886_bb0180","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1038\/nrgastro.2017.32","article-title":"Lipid droplets and liver disease: from basic biology to clinical implications","volume":"14","author":"Gluchowski","year":"2017","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.bbadis.2025.167886_bb0185","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s43066-020-00043-x","article-title":"Recent advances in non-invasive diagnosis and medical management of non-alcoholic fatty liver disease in adult","volume":"10","author":"Paul","year":"2020","journal-title":"Egypt. Liver J."},{"issue":"10","key":"10.1016\/j.bbadis.2025.167886_bb0190","doi-asserted-by":"crossref","first-page":"2537","DOI":"10.1016\/j.cell.2021.04.015","article-title":"Mechanisms and disease consequences of nonalcoholic fatty liver disease","volume":"184","author":"Loomba","year":"2021","journal-title":"Cell"},{"issue":"4","key":"10.1016\/j.bbadis.2025.167886_bb0195","first-page":"G462","article-title":"Hepatic transcriptome signatures in patients with varying degrees of nonalcoholic fatty liver disease compared with healthy normal-weight individuals. American journal of physiology-gastrointestinal and liver","volume":"316","author":"Suppli","year":"2019","journal-title":"Physiology"},{"key":"10.1016\/j.bbadis.2025.167886_bb0200","doi-asserted-by":"crossref","unstructured":"Govaere O, Cockell S, Tiniakos D, Queen R, Younes R, Vacca M, Alexander L, Ravaioli F, Palmer J, Petta S, Boursier J. Transcriptomic profiling across the nonalcoholic fatty liver disease spectrum reveals gene signatures for steatohepatitis and fibrosis. Sci. Transl. Med. 2020 Dec 2;12(572):eaba4448.","DOI":"10.1126\/scitranslmed.aba4448"},{"issue":"8","key":"10.1016\/j.bbadis.2025.167886_bb0205","doi-asserted-by":"crossref","first-page":"3501","DOI":"10.1172\/JCI74438","article-title":"Periostin promotes liver steatosis and hypertriglyceridemia through downregulation of PPAR\u03b1","volume":"124","author":"Lu","year":"2014","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bbadis.2025.167886_bb0210","doi-asserted-by":"crossref","unstructured":"Bai L, Qu W, Cheng X, Yang H, Huang YP, Wang Z, Han C, Tian RF, Hu F, Yang L, Tian S. Multispecies transcriptomics identifies SIKE as a MAPK repressor that prevents NASH progression. Sci. Transl. Med. 2024 Feb 14;16(734):eade7347.","DOI":"10.1126\/scitranslmed.ade7347"},{"issue":"3","key":"10.1016\/j.bbadis.2025.167886_bb0215","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1097\/MOL.0000000000000080","article-title":"Fatty acid sources and their fluxes as they contribute to plasma triglyceride concentrations and fatty liver in humans","volume":"25","author":"Jacome-Sosa","year":"2014","journal-title":"Curr. Opin. Lipidol."},{"issue":"3","key":"10.1016\/j.bbadis.2025.167886_bb0220","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1053\/j.gastro.2013.11.049","article-title":"Increased de novo lipogenesis is a distinct characteristic of individuals with nonalcoholic fatty liver disease","volume":"146","author":"Lambert","year":"2014","journal-title":"Gastroenterology"},{"issue":"2","key":"10.1016\/j.bbadis.2025.167886_bb0225","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1210\/en.2015-1866","article-title":"Hepatocyte-specific disruption of CD36 attenuates fatty liver and improves insulin sensitivity in HFD-fed mice","volume":"157","author":"Wilson","year":"2016","journal-title":"Endocrinology"},{"key":"10.1016\/j.bbadis.2025.167886_bb0230","doi-asserted-by":"crossref","unstructured":"Zeng H, Qin H, Liao M, Zheng E, Luo X, Xiao A, Li Y, Chen L, Wei L, Zhao L, Ruan XZ. CD36 promotes de novo lipogenesis in hepatocytes through INSIG2-dependent SREBP1 processing. Mol. Metab. 2022 Mar 1;57:101428.","DOI":"10.1016\/j.molmet.2021.101428"},{"key":"10.1016\/j.bbadis.2025.167886_bb0235","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1007\/s10620-016-4054-0","article-title":"Role of dietary fructose and hepatic de novo lipogenesis in fatty liver disease","volume":"61","author":"Softic","year":"2016","journal-title":"Dig. Dis. Sci."},{"key":"10.1016\/j.bbadis.2025.167886_bb0240","doi-asserted-by":"crossref","unstructured":"Hodson L, Gunn PJ. The regulation of hepatic fatty acid synthesis and partitioning: the effect of nutritional state. Nat. Rev. Endocrinol. 2019 Dec;15(12):689\u2013700.","DOI":"10.1038\/s41574-019-0256-9"},{"issue":"4","key":"10.1016\/j.bbadis.2025.167886_bb0245","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.livres.2023.11.003","article-title":"In-depth analysis of de novo lipogenesis in non-alcoholic fatty liver disease: mechanism and pharmacological interventions","volume":"7","author":"Zhu","year":"2023","journal-title":"Liver Res."},{"key":"10.1016\/j.bbadis.2025.167886_bb0250","doi-asserted-by":"crossref","unstructured":"Bence KK, Birnbaum MJ. Metabolic drivers of non-alcoholic fatty liver disease. Mol. metab. 2021 Aug 1;50:101143.","DOI":"10.1016\/j.molmet.2020.101143"},{"issue":"1","key":"10.1016\/j.bbadis.2025.167886_bb0255","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.cels.2017.12.006","article-title":"Integration of multi-omics data from mouse diversity panel highlights mitochondrial dysfunction in non-alcoholic fatty liver disease","volume":"6","author":"Krishnan","year":"2018","journal-title":"Cell Syst."},{"issue":"6","key":"10.1016\/j.bbadis.2025.167886_bb0260","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1016\/j.jhep.2005.03.004","article-title":"NASH: a mitochondrial disease","volume":"42","author":"Pessayre","year":"2005","journal-title":"J. Hepatol."},{"key":"10.1016\/j.bbadis.2025.167886_bb0265","doi-asserted-by":"crossref","unstructured":"Shum M, Ngo J, Shirihai OS, Liesa M. Mitochondrial oxidative function in NAFLD: friend or foe?. Mol. Metab. 2021 Aug 1;50:101134.","DOI":"10.1016\/j.molmet.2020.101134"},{"issue":"1","key":"10.1016\/j.bbadis.2025.167886_bb0270","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.mito.2005.10.004","article-title":"Mitochondrial dysfunction in NASH: causes, consequences and possible means to prevent it","volume":"6","author":"Begriche","year":"2006","journal-title":"Mitochondrion"},{"issue":"4","key":"10.1016\/j.bbadis.2025.167886_bb0275","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1002\/hep.26226","article-title":"Mitochondrial adaptations and dysfunctions in nonalcoholic fatty liver disease","volume":"58","author":"Begriche","year":"2013","journal-title":"Hepatology"},{"issue":"5","key":"10.1016\/j.bbadis.2025.167886_bb0280","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/j.cmet.2015.04.004","article-title":"Adaptation of hepatic mitochondrial function in humans with non-alcoholic fatty liver is lost in steatohepatitis","volume":"21","author":"Koliaki","year":"2015","journal-title":"Cell Metab."},{"key":"10.1016\/j.bbadis.2025.167886_bb0285","doi-asserted-by":"crossref","unstructured":"Lu Q, Tian X, Wu H, Huang J, Li M, Mei Z, Zhou L, Xie H, Zheng S. Metabolic changes of hepatocytes in NAFLD. Front. Physiol. 2021 Aug 30;12:710420.","DOI":"10.3389\/fphys.2021.710420"},{"issue":"5","key":"10.1016\/j.bbadis.2025.167886_bb0290","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1016\/j.jhep.2020.11.028","article-title":"Acetylation of lactate dehydrogenase B drives NAFLD progression by impairing lactate clearance","volume":"74","author":"Wang","year":"2021","journal-title":"J. Hepatol."},{"issue":"7678","key":"10.1016\/j.bbadis.2025.167886_bb0295","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1038\/nature24057","article-title":"Glucose feeds the TCA cycle via circulating lactate","volume":"551","author":"Hui","year":"2017","journal-title":"Nature"},{"issue":"6","key":"10.1016\/j.bbadis.2025.167886_bb0300","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1016\/j.cmet.2011.11.004","article-title":"Excessive hepatic mitochondrial TCA cycle and gluconeogenesis in humans with nonalcoholic fatty liver disease","volume":"14","author":"Sunny","year":"2011","journal-title":"Cell Metab."},{"issue":"6","key":"10.1016\/j.bbadis.2025.167886_bb0305","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1194\/jlr.M023382","article-title":"Elevated TCA cycle function in the pathology of diet-induced hepatic insulin resistance and fatty liver [S]","volume":"53","author":"Satapati","year":"2012","journal-title":"J. Lipid Res."},{"issue":"2","key":"10.1016\/j.bbadis.2025.167886_bb0310","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.jhep.2022.09.020","article-title":"Mitochondrial alterations in fatty liver diseases","volume":"78","author":"Fromenty","year":"2023","journal-title":"J. Hepatol."},{"issue":"4","key":"10.1016\/j.bbadis.2025.167886_bb0315","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1016\/j.cmet.2023.03.007","article-title":"Global determination of reaction rates and lipid turnover kinetics in Mus musculus","volume":"35","author":"Chen","year":"2023","journal-title":"Cell Metab."},{"issue":"11","key":"10.1016\/j.bbadis.2025.167886_bb0320","doi-asserted-by":"crossref","first-page":"2437","DOI":"10.1016\/j.cmet.2024.10.001","article-title":"Amino acid is a major carbon source for hepatic lipogenesis","volume":"36","author":"Liao","year":"2024","journal-title":"Cell Metab."},{"issue":"3","key":"10.1016\/j.bbadis.2025.167886_bb0325","first-page":"G567","article-title":"Glycine and urea kinetics in nonalcoholic steatohepatitis in human: effect of intralipid infusion. American journal of physiology-gastrointestinal and liver","volume":"297","author":"Dasarathy","year":"2009","journal-title":"Physiology"},{"issue":"9","key":"10.1016\/j.bbadis.2025.167886_bb0330","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1111\/j.1478-3231.2009.02076.x","article-title":"Liver fat and lipid oxidation in humans","volume":"29","author":"Kotronen","year":"2009","journal-title":"Liver Int."},{"issue":"11","key":"10.1016\/j.bbadis.2025.167886_bb0335","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1136\/gutjnl-2012-302789","article-title":"Whole-body substrate metabolism is associated with disease severity in patients with non-alcoholic fatty liver disease","volume":"62","author":"Croci","year":"2013","journal-title":"Gut"},{"issue":"9","key":"10.1016\/j.bbadis.2025.167886_bb0340","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1111\/hepr.12825","article-title":"Increased lipogenesis in spite of upregulated hepatic 5\u2019AMP-activated protein kinase in human non-alcoholic fatty liver","volume":"47","author":"von Loeffelholz","year":"2017","journal-title":"Hepatol. Res."},{"issue":"3","key":"10.1016\/j.bbadis.2025.167886_bb0345","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1038\/nrgastro.2016.185","article-title":"Autophagy in the liver: functions in health and disease","volume":"14","author":"Ueno","year":"2017","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.bbadis.2025.167886_bb0350","doi-asserted-by":"crossref","unstructured":"Ramos VD, Kowaltowski AJ, Kakimoto PA. Autophagy in hepatic steatosis: a structured review. Front. cell dev. biol. 2021 Apr 15;9:657389.","DOI":"10.3389\/fcell.2021.657389"},{"issue":"1","key":"10.1016\/j.bbadis.2025.167886_bb0355","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1096\/fj.201601393R","article-title":"Defective lysosomal clearance of autophagosomes and its clinical implications in nonalcoholic steatohepatitis","volume":"32","author":"Wang","year":"2018","journal-title":"FASEB J."},{"issue":"6","key":"10.1016\/j.bbadis.2025.167886_bb0360","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.tem.2011.02.003","article-title":"Regulation of lipid droplets by autophagy","volume":"22","author":"Dong","year":"2011","journal-title":"Trends Endocrinol. Metab."},{"issue":"1","key":"10.1016\/j.bbadis.2025.167886_bb0365","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2021.103549","article-title":"In vitro models for non-alcoholic fatty liver disease: emerging platforms and their applications","volume":"25","author":"Ramos","year":"2022","journal-title":"Iscience"},{"issue":"16","key":"10.1016\/j.bbadis.2025.167886_bb0370","doi-asserted-by":"crossref","first-page":"4992","DOI":"10.1158\/0008-5472.CAN-13-0308","article-title":"Metabolic characterization of hepatocellular carcinoma using nontargeted tissue metabolomics","volume":"73","author":"Huang","year":"2013","journal-title":"Cancer Res."},{"issue":"1","key":"10.1016\/j.bbadis.2025.167886_bb0375","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.cmet.2015.12.006","article-title":"The emerging hallmarks of cancer metabolism","volume":"23","author":"Pavlova","year":"2016","journal-title":"Cell Metab."},{"issue":"1","key":"10.1016\/j.bbadis.2025.167886_bb0380","doi-asserted-by":"crossref","first-page":"36","DOI":"10.3390\/jcm10010036","article-title":"In vitro and in vivo models of non-alcoholic fatty liver disease: a critical appraisal","volume":"10","author":"Soret","year":"2020","journal-title":"J. Clin. Med."},{"issue":"16","key":"10.1016\/j.bbadis.2025.167886_bb0385","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.redox.2018.03.004","article-title":"Sorting cells alters their redox state and cellular metabolome","volume":"1","author":"Llufrio","year":"2018","journal-title":"Redox Biol."},{"key":"10.1016\/j.bbadis.2025.167886_bb0390","doi-asserted-by":"crossref","first-page":"2001517","DOI":"10.1002\/adhm.202001517","article-title":"Current advances on 3D-bioprinted liver tissue models","volume":"9","author":"Ma","year":"2020","journal-title":"Adv. Healthc. Mater."},{"key":"10.1016\/j.bbadis.2025.167886_bb0395","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/j.jcmgh.2017.11.012","article-title":"Bioengineered liver models for drug testing and cell differentiation studies","volume":"5","author":"Underhill","year":"2018","journal-title":"Cell. Mol. Gastroenterol.Hepatol."},{"key":"10.1016\/j.bbadis.2025.167886_bb0400","doi-asserted-by":"crossref","first-page":"2001284","DOI":"10.1002\/adhm.202001284","article-title":"Engineered microsystems for spheroid and organoid studies","volume":"10","author":"Kang","year":"2021","journal-title":"Adv. Healthc. Mater."},{"key":"10.1016\/j.bbadis.2025.167886_bb0405","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/s12072-018-9913-7","article-title":"Precision-cut liver slices: a versatile tool to advance liver research","volume":"13","author":"Palma","year":"2019","journal-title":"Hepatol. Int."},{"key":"10.1016\/j.bbadis.2025.167886_bb0410","series-title":"GENFIT: Announces Results from Interim Analysis of RESOLVE-IT Phase 3 Trial of Elafibranor Ina Adults with NASH and Fibrosis","author":"GENFIT S","year":"2020"},{"key":"10.1016\/j.bbadis.2025.167886_bb0415","unstructured":"http:\/\/www.wklab.org\/wp-content\/uploads\/2016\/02\/Palmitate-SA_Prep_SOP_v08062 4.pdf 160."},{"key":"10.1016\/j.bbadis.2025.167886_bb0420","doi-asserted-by":"crossref","unstructured":"Challa TD, Wueest S, Lucchini FC, Dedual M, Modica S, Borsigova M, Wolfrum C, Bl\u00fcher M, Konrad D. Liver ASK1 protects from non-alcoholic fatty liver disease and fibrosis. EMBO Mol. Med. 2019 Oct;11(10):e10124.","DOI":"10.15252\/emmm.201810124"},{"issue":"1\u20132","key":"10.1016\/j.bbadis.2025.167886_bb0425","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0022-1759(83)90303-4","article-title":"Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays","volume":"65","author":"Mosmann","year":"1983","journal-title":"J. Immunol. Methods"},{"issue":"1","key":"10.1016\/j.bbadis.2025.167886_bb0430","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2020.108223","article-title":"The lipid handling capacity of subcutaneous fat is programmed by mTORC2 during development","volume":"33","author":"Hsiao","year":"2020","journal-title":"Cell Rep."},{"key":"10.1016\/j.bbadis.2025.167886_bb0435","doi-asserted-by":"crossref","unstructured":"Nishad A, Naseem A, Rani S, Malik S. Automated qualitative batch measurement of lipid droplets in the liver of bird using ImageJ. STAR protocols. 2023 Sep 15;4(3):102466.","DOI":"10.1016\/j.xpro.2023.102466"},{"issue":"5","key":"10.1016\/j.bbadis.2025.167886_bb0440","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1080\/15376516.2020.1747124","article-title":"Automated lipid droplet quantification system for phenotypic analysis of adipocytes using CellProfiler","volume":"30","author":"Adomshick","year":"2020","journal-title":"Toxicol. Mech. Methods"},{"key":"10.1016\/j.bbadis.2025.167886_bb0445","doi-asserted-by":"crossref","unstructured":"Martin M. Cutadapt removes adapter sequences from high-throughput sequencing reads. EMBnet. journal. 2011 May 2;17(1):10\u20132.","DOI":"10.14806\/ej.17.1.200"},{"issue":"4","key":"10.1016\/j.bbadis.2025.167886_bb0450","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1038\/nmeth.4197","article-title":"Salmon provides fast and bias-aware quantification of transcript expression","volume":"14","author":"Patro","year":"2017","journal-title":"Nat. Methods"},{"key":"10.1016\/j.bbadis.2025.167886_bb0455","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13059-014-0550-8","article-title":"Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2","volume":"15","author":"Love","year":"2014","journal-title":"Genome Biol."},{"key":"10.1016\/j.bbadis.2025.167886_bb0460","doi-asserted-by":"crossref","unstructured":"Korotkevich G, Sukhov V, Budin N, Shpak B, Artyomov MN, Sergushichev A. Fast gene set enrichment analysis. biorxiv. 2016 Jun 20:060012.","DOI":"10.1101\/060012"},{"key":"10.1016\/j.bbadis.2025.167886_bb0465","doi-asserted-by":"crossref","first-page":"2969","DOI":"10.3390\/cells11192969","article-title":"NSP4 and ORF9b of SARS-CoV-2 induce pro-inflammatory mitochondrial DNA release in inner membrane-derived vesicles","volume":"11","author":"Faizan","year":"2022","journal-title":"Cells"},{"issue":"7","key":"10.1016\/j.bbadis.2025.167886_bb0470","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1093\/bioinformatics\/btq054","article-title":"Skyline: an open source document editor for creating and analyzing targeted proteomics experiments","volume":"26","author":"MacLean","year":"2010","journal-title":"Bioinformatics"},{"issue":"3","key":"10.1016\/j.bbadis.2025.167886_bb0475","doi-asserted-by":"crossref","first-page":"214","DOI":"10.3390\/cells13030214","article-title":"Moderate elevation of homocysteine induces endothelial dysfunction through adaptive UPR activation and metabolic rewiring","volume":"13","author":"Chatterjee","year":"2024","journal-title":"Cells"},{"key":"10.1016\/j.bbadis.2025.167886_bb0480","doi-asserted-by":"crossref","unstructured":"Rogers GW, Nadanaciva S, Swiss R, Divakaruni AS, Will Y. Assessment of fatty acid beta oxidation in cells and isolated mitochondria. Curr. Protoc. Toxicol. 2014 May;60(1):25\u20133.","DOI":"10.1002\/0471140856.tx2503s60"},{"key":"10.1016\/j.bbadis.2025.167886_bb0485","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1038\/s41419-023-05810-3","article-title":"Obesity impairs cardiolipin-dependent mitophagy and therapeutic intercellular mitochondrial transfer ability of mesenchymal stem cells","volume":"14","author":"Sagar","year":"2023","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.bbadis.2025.167886_bb0490","doi-asserted-by":"crossref","unstructured":"Peters AE, Caban SJ, McLaughlin EA, Roman SD, Bromfield EG, Nixon B, Sutherland JM. The impact of aging on macroautophagy in the pre-ovulatory mouse oocyte. Front. Cell Dev. Biol. 2021 Jun 29;9:691826.","DOI":"10.3389\/fcell.2021.691826"},{"issue":"5","key":"10.1016\/j.bbadis.2025.167886_bb0495","doi-asserted-by":"crossref","first-page":"709","DOI":"10.3390\/biom12050709","article-title":"A high throughput lipidomics method using scheduled multiple reaction monitoring","volume":"12","author":"Bhaskar","year":"2022","journal-title":"Biomolecules"}],"container-title":["Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0925443925002340?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0925443925002340?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T06:33:19Z","timestamp":1762324399000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0925443925002340"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":99,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,8]]}},"alternative-id":["S0925443925002340"],"URL":"https:\/\/doi.org\/10.1016\/j.bbadis.2025.167886","relation":{},"ISSN":["0925-4439"],"issn-type":[{"value":"0925-4439","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Generation and characterization of a chronic in vitro model to study the early stage of metabolic dysfunction-associated steatotic liver disease (MASLD)","name":"articletitle","label":"Article Title"},{"value":"Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbadis.2025.167886","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"167886"}}